Canagliflozin for Prevention of Cardiovascular and Renal Outcomes in type2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled TrialsLei Tian, Yaoxian Wang, Yuzi Cai et al.|Frontiers in Pharmacology|2021Cited by 32